Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reuben S Harris

Showing results (151-160 of 267) with videos related to

Pageof 27
Sort By:
Nature Communications|May 1, 2026
A viral APOBEC3 antagonist distinguishes HHV-6A from HHV-6BJun Arii, Salma Aktar, Jing Rin Huang, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Murine models for triple-negative breast cancer with differential responsiveness to immunotherapyThomas J Kalantzakos, Yufan Zhou, Xingyu Liu, et al.
Viruses|March 6, 2021
APOBECs and HerpesvirusesAdam Z Cheng, Sofia N Moraes, Nadine M Shaban, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2021
Structural basis for recognition of distinct deaminated DNA lesions by endonuclease QKe Shi, Nicholas H Moeller, Surajit Banerjee, et al.
Cell Reports|October 31, 2019
HIV-1 Vif Triggers Cell Cycle Arrest by Degrading Cellular PPP2R5 Phospho-regulatorsDaniel J Salamango, Terumasa Ikeda, Seyed Arad Moghadasi, et al.
BMC Molecular Biology|July 30, 2013
APOBEC3 inhibits DEAD-END function to regulate microRNA activitySara Ali, Namrata Karki, Chitralekha Bhattacharya, et al.
Plos Genetics|November 21, 2014
Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivityEric W Refsland, Judd F Hultquist, Elizabeth M Luengas, et al.
Leukemia|March 9, 2024
Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifierSarah Grasedieck, Afsaneh Panahi, Matthew C Jarvis, et al.
Journal of Virology|October 23, 2015
A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus InfectionRokusuke Yoshikawa, Taisuke Izumi, Eri Yamada, et al.
Blood|May 31, 2012
APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repairRoni Nowarski, Ofer I Wilner, Ori Cheshin, et al.
Pageof 27

Showing results (151-160 of 267) with videos related to

Sort By:
Pageof 27
Nature Communications|May 1, 2026
A viral APOBEC3 antagonist distinguishes HHV-6A from HHV-6BJun Arii, Salma Aktar, Jing Rin Huang, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Murine models for triple-negative breast cancer with differential responsiveness to immunotherapyThomas J Kalantzakos, Yufan Zhou, Xingyu Liu, et al.
Viruses|March 6, 2021
APOBECs and HerpesvirusesAdam Z Cheng, Sofia N Moraes, Nadine M Shaban, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2021
Structural basis for recognition of distinct deaminated DNA lesions by endonuclease QKe Shi, Nicholas H Moeller, Surajit Banerjee, et al.
Cell Reports|October 31, 2019
HIV-1 Vif Triggers Cell Cycle Arrest by Degrading Cellular PPP2R5 Phospho-regulatorsDaniel J Salamango, Terumasa Ikeda, Seyed Arad Moghadasi, et al.
BMC Molecular Biology|July 30, 2013
APOBEC3 inhibits DEAD-END function to regulate microRNA activitySara Ali, Namrata Karki, Chitralekha Bhattacharya, et al.
Plos Genetics|November 21, 2014
Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivityEric W Refsland, Judd F Hultquist, Elizabeth M Luengas, et al.
Leukemia|March 9, 2024
Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifierSarah Grasedieck, Afsaneh Panahi, Matthew C Jarvis, et al.
Journal of Virology|October 23, 2015
A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus InfectionRokusuke Yoshikawa, Taisuke Izumi, Eri Yamada, et al.
Blood|May 31, 2012
APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repairRoni Nowarski, Ofer I Wilner, Ori Cheshin, et al.
Pageof 27